15 μg/kg
Species: Equidae · Tissue: Fat
Marker residue: Firocoxib
Therapeutic class: Anti-inflammatory agents/Nonsteroidal anti-inflammatory agents
156 authorised products across national registers.
Italy — Ministero della Salute
France — ANSES-ANMV
Spain — CIMAVet (AEMPS)
United Kingdom — VMD
United States — DailyMed (NLM)
United States — FDA Green Book
Canada — Health Canada DPD
Species: Equidae · Tissue: Fat
Marker residue: Firocoxib
Therapeutic class: Anti-inflammatory agents/Nonsteroidal anti-inflammatory agents
Species: Equidae · Tissue: Kidney
Marker residue: Firocoxib
Therapeutic class: Anti-inflammatory agents/Nonsteroidal anti-inflammatory agents
Species: Equidae · Tissue: Liver
Marker residue: Firocoxib
Therapeutic class: Anti-inflammatory agents/Nonsteroidal anti-inflammatory agents
Species: Equidae · Tissue: Muscle
Marker residue: Firocoxib
Therapeutic class: Anti-inflammatory agents/Nonsteroidal anti-inflammatory agents
No antimicrobial-resistance surveillance is recorded for this substance.
Spontaneous adverse-event reports that name Firocoxib, by species — reported counts, not proven reactions.
Top reactions: Vomiting (2,519) · Anorexia (1,326) · Elevated blood urea nitrogen (BUN) (1,078) · Diarrhoea (932) · Elevated creatinine (807)
Top reactions: Diarrhoea (32) · Lack of efficacy - NOS (31) · Colic (26) · Anorexia (24) · Death by euthanasia (24)
Source: openFDA Animal & Veterinary adverse-event reports.
Reading about Firocoxib? Pet products get recalled all the time — get a free email when a new pet-relevant recall is published. Unsubscribe any time.
Opt-in only: we store your email, language, optional species filter and the page you signed up on, and send a welcome email with a one-click unsubscribe link. We never share your address.